ID   CIBi008-A
AC   CVCL_ZX44
SY   Beta-thala iPSC
DR   BioSamples; SAMEA8152170
DR   hPSCreg; CIBi008-A
DR   Wikidata; Q102113680
RX   PubMed=33157391;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.-78A>G (-28A>G); ClinVar=VCV000015471; Zygosity=Heterozygous (PubMed=33157391).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.316-197C>T (IVS2-654C>T); ClinVar=VCV000015458; Zygosity=Heterozygous (PubMed=33157391).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
RX   PubMed=33157391; DOI=10.1016/j.scr.2020.102074;
RA   Wu, Sui-Han
RA   Wei, Hong-Jun
RA   Chu, Meng
RA   Weng, Zhan-Ping
RT   "Generation of a human iPSC line CIBi008-A from amniotic fluid-derived
RT   cells of a fetus with beta-thalassemia carrying variants of -28A > G
RT   and IVS-II-654C > T in HBB.";
RL   Stem Cell Res. 49:102074-102074(2020).
//